Legislation removes FDA involvement when patients seek experimental medications. Here’s what critics and proponents say.
New drugs for acute migraines are almost ready for prime time. Here's what you need to know.
Learning more about popular dietary supplements could further cement pharmacists’ position in the healthcare industry, helping them gain recognition as healthcare providers.
Is new technology actually making pharmacy any better (or easier)?
PBMs are evolving, but what will they be evolving into and will they be more transparent?
When pharmacists manage drug therapy for physicians, diabetes patients see a significant improvement in key measures.
Pharmacists who practice cultural awareness can deliver better patient care and bring about better outcomes
The term "cardiometabolic disorders" (CMD) refers to a cluster of interrelated risk factors (hypertension, elevated fasting glucose, reduced high-density lipoprotein, elevated triglycerides, and abdominal obesity) that promote the development of atherosclerotic cardiovascular disease and type 2 diabetes. With an estimated 47 million Americans facing increased risk of heart disease because of these conditions, management of patients' CMD is a priority for pharmacists.
Commercial medication therapy management programs are gaining in strength and popularity for medical, financial, and practical reasons. In Minnesota, a pilot program for state employees was so successful that two years later it expanded into a program for all fully insured members. Another program is in use by Minnesota Medicaid and General Mills. And in North Carolina, the Asheville Project is still going strong.